Table 3. Pair-wise analysis of homozygous/heterozygous state in controls, total WNV cases and WNND/WNF* subpopulations.
Gene | Controls | Cases | Cases vs Controls | Cases | WNND vs Controls | WNND vs WNF | |
---|---|---|---|---|---|---|---|
WNND | WNF | ||||||
DPA | n = 99 | n = 102 | p-value** | n = 68 | n = 34 | p-value** | p-value** |
Homo | 71 (71.7%) | 73 (71.6%) | 1.000 | 48 (70.6%) | 25 (73.5%) | 1.000 | 0.8193 |
Hetero | 28 (28.3%) | 29 (28.4%) | 20 (29.4%) | 9 (26.5%) | |||
DQA | n = 81 | n = 89 | n = 58 | n = 31 | |||
Homo | 61 (75.3%) | 80 (89.9%) | 0.0142 | 51 (87.9%) | 29 (93.5%) | 0.0822 | 0.4869 |
Hetero | 20 (24.7%) | 9 (10.1%) | 7 (12.1%) | 2 (6.5%) | |||
DRB | n = 84 | n = 91 | n = 59 | n = 32 | |||
Homo | 62 | 53 (58.2%) | 0.0382 | 34 (57.6%) | 19 (59.4%) | 0.0484 | 1.000 |
(73.8%) | |||||||
Hetero | 22 | 38 (41.8%) | 25 (42.4%) | 13 (41.6%) | |||
(26.2%) |
*WNND (West Nile Neuroinvasive Disease), WNF (West Nile Fever).
**Fisher's exact test.